This archive report was first published on 19 September 2019.
HPV Vaccine Rollout in Kenya: What You Need to Know ¶
As of September 19, 2019, the Kenyan government will launch a nationwide campaign to vaccinate young girls aged 10 against the risk of contracting cervical cancer.
The vaccine, Gardasil, will be administered free of charge at over 9,000 public, private, and faith-based health facilities across the country.
HPV, or human papillomavirus, is a common viral infection that can cause warts and, in some cases, lead to cancer. According to the World Health Organisation, virtually all cervical cancer cases (99%) are linked to genital infection with HPV.
The vaccine is most effective when administered between the ages of nine and 14, and the Kenyan government has chosen to vaccinate girls aged 10 due to a global shortage of the HPV vaccine.
HPV is a highly contagious infection that can be spread through skin-to-skin contact, and it is estimated that most people will contract the virus at some point in their lives. However, the vaccine can help prevent the development of cervical cancer and genital warts.
The vaccine is available in private health facilities for those over 10 years old, with a cost ranging from Sh3,000 to Sh5,000.
It is essential to note that the vaccine is not a guarantee against HPV infection, but it can significantly reduce the risk of developing cervical cancer and genital warts.
